{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:40:33Z","timestamp":1793979633542,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Total body irradiation (TBI)-based-conditioning before allogeneic hematopoietic stem cell transplantation (allo-HSCT) is standard of care in patients with acute myeloid leukemia (AML) but can cause long-term morbidity. Data on the impact of chronic Graft-versus-host disease (cGvHD) on cognitive function (CF) and quality of life (QoL) of long-term transplant survivors are sparse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed patient-reported outcomes focusing on progression-free AML patients and 1st allo-HSCT applying a standardized TBI-technique with an average dose rate of 4\u00a0cGy\/min to the total body and lung shielding in case of doses\u2009&gt;\u20098\u00a0Gy. Instruments included the Functional Assessment of Cancer Therapy-Bone marrow transplant (FACT-BMT, version 4), the FACT-Cognition Function (FACT-Cog, version 3) and the Patient Health Questionaire-4 (PHQ-4). We put focus on the impact of cGvHD and compared the results to normative data derived from the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 41 eligible patients contacted, 32 (78.0%) patients with a medium follow-up of 154 months (Interquartile range 113, 191 months) participated in the study. Eleven patients (34.4%) had active cGvHD, 11 (34.4%) resolved cGvHD and 10 (31.3%) never had cGvHD. Patients with active cGvHD had poorer FACT-BMT, FACT-Cog and higher PHQ-4 scores compared to patients with resolved cGvHD or who never had cGvHD. Outcomes were similar in patients with resolved cGvHD and those who never had cGvHD. Patients with active cGvHD had similar FACT-Cog, but lower FACT-BMT in comparison to normative data. However, the overall patient sample had similar FACT-BMT and FACT-Cog in comparison to normative data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data indicate that CF of long-term survivors upon TBI-based allo-HSCT is not impaired, even in the presence of active cGvHD. However, active cGvHD has a negative impact on QoL.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      \u00a0\u00a0The local Ethics Board of the University of Regensburg approved this study (Number 20-1810_1-101).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-022-02161-9","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T05:02:58Z","timestamp":1669698178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7435-9337","authenticated-orcid":false,"given":"Isabella","family":"Gruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Koelbl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Holler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Edinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"issue":"22","key":"2161_CR1","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091\u2013101. https:\/\/doi.org\/10.1056\/NEJMoa1004383.","journal-title":"N Engl J Med"},{"issue":"9","key":"2161_CR2","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1182\/blood-2002-07-2231","volume":"101","author":"G Soci\u00e9","year":"2003","unstructured":"Soci\u00e9 G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101(9):3373\u201385. https:\/\/doi.org\/10.1182\/blood-2002-07-2231.","journal-title":"Blood"},{"issue":"7","key":"2161_CR3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/PON.3159","volume":"22","author":"A Scherwath","year":"2013","unstructured":"Scherwath A, Schirmer L, Kruse M, et al. Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study. Psychooncology. 2013;22(7):1509\u201316. https:\/\/doi.org\/10.1002\/PON.3159.","journal-title":"Psychooncology"},{"issue":"8","key":"2161_CR4","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912\u20139. https:\/\/doi.org\/10.1182\/blood-2005-05-2004.","journal-title":"Blood"},{"issue":"4","key":"2161_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424\u201347. https:\/\/doi.org\/10.1182\/blood-2016-08-733196.","journal-title":"Blood"},{"key":"2161_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0658-y","author":"PM H\u00e4rtl","year":"2016","unstructured":"H\u00e4rtl PM, Treutwein M, Hautmann MG, et al. Total body irradiation-an attachment free sweeping beam technique. Radiat Oncol. 2016. https:\/\/doi.org\/10.1186\/s13014-016-0658-y.","journal-title":"Radiat Oncol."},{"issue":"3","key":"2161_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease: I\u2014The 2014 diagnosis and staging Working Group Report. Biol Blood Marrow Transpl. 2015;21(3):389\u2013401.e1. https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.001.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"2161_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/J.BBMT.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease: I\u2014diagnosis and staging Working Group Report. Biol Blood Marrow Transpl. 2005;11(12):945\u201356. https:\/\/doi.org\/10.1016\/J.BBMT.2005.09.004.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2161_CR9","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","volume":"53","author":"HM Schoemans","year":"2018","unstructured":"Schoemans HM, Lee SJ, Ferrara JL, et al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology and guidance for graft-versus-host disease assessment. Bone Marrow Transpl. 2018;53:1401\u201315. https:\/\/doi.org\/10.1038\/s41409-018-0204-7.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"2161_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/0163278705275341","volume":"28","author":"PS Brucker","year":"2005","unstructured":"Brucker PS, Yost K, Cashy J, Webster K, Cella D. General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G). Eval Heal Prof. 2005;28(2):192\u2013211. https:\/\/doi.org\/10.1177\/0163278705275341.","journal-title":"Eval Heal Prof"},{"issue":"3","key":"2161_CR11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/09602011.2015.1036890","volume":"26","author":"M Lange","year":"2016","unstructured":"Lange M, Heutte N, Morel N, Eustache F, Joly F, Giffard B. Cognitive complaints in cancer: the french version of the Functional Assessment of Cancer Therapy-Cognitive function (FACT-Cog), normative data from a healthy population. Neuropsychol Rehabil. 2016;26(3):392\u2013409. https:\/\/doi.org\/10.1080\/09602011.2015.1036890.","journal-title":"Neuropsychol Rehabil"},{"issue":"5","key":"2161_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.mlr.0000062554.74615.4c","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in Health-related quality of life. Med Care. 2003;41(5):582\u201392. https:\/\/doi.org\/10.1097\/01.mlr.0000062554.74615.4c.","journal-title":"Med Care"},{"issue":"1","key":"2161_CR13","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1093\/jncics\/pkz099","volume":"4","author":"K Van Dyk","year":"2020","unstructured":"Van Dyk K, Crespi CM, Petersen L, Ganz PA. Identifying cancer-related cognitive impairment using the FACT-Cog perceived cognitive impairment. JNCI Cancer Spectr. 2020;4(1):2019\u201321. https:\/\/doi.org\/10.1093\/jncics\/pkz099.","journal-title":"JNCI Cancer Spectr"},{"issue":"9","key":"2161_CR14","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.3324\/haematol.2018.192930","volume":"103","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Onstad L, Chow EJ, et al. Patient-reported outcomes and health status associated with chronic graft-versus-host disease. Haematologica. 2018;103(9):1535\u201341. https:\/\/doi.org\/10.3324\/haematol.2018.192930.","journal-title":"Haematologica"},{"key":"2161_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq245","author":"O Grauer","year":"2010","unstructured":"Grauer O, Wolff D, Bertz H, et al. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the consensus conference\u00a0on clinical practice in chronic graft-versus-host disease. AJ Neurol. 2010. https:\/\/doi.org\/10.1093\/brain\/awq245.","journal-title":"AJ Neurol"},{"issue":"9","key":"2161_CR16","doi-asserted-by":"publisher","first-page":"e44922","DOI":"10.1371\/journal.pone.0044922","volume":"7","author":"PD Kraus","year":"2012","unstructured":"Kraus PD, Wolff D, Grauer O, et al. Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease. PLoS ONE. 2012;7(9):e44922. https:\/\/doi.org\/10.1371\/journal.pone.0044922.","journal-title":"PLoS ONE"},{"key":"2161_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/sj.bmt.1703677","volume":"30","author":"N Worel","year":"2002","unstructured":"Worel N, Biener D, Kalhs P, et al. Quality of life long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transpl. 2002;30:619\u201326. https:\/\/doi.org\/10.1038\/sj.bmt.1703677.","journal-title":"Bone Marrow Transpl"},{"key":"2161_CR18","doi-asserted-by":"publisher","unstructured":"Fraser CJ, Bhatia S, Ness K, et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the bone marrow transplant Survivor Study. Published online 2006. https:\/\/doi.org\/10.1182\/blood-2006-02-003954.","DOI":"10.1182\/blood-2006-02-003954"},{"issue":"9","key":"2161_CR19","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/bmt.2015.137","volume":"50","author":"S Kurosawa","year":"2015","unstructured":"Kurosawa S, Yamaguchi T, Mori T, et al. Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia. Bone Marrow Transpl. 2015;50(9):1241\u20139. https:\/\/doi.org\/10.1038\/bmt.2015.137.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"2161_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2008-10-182592","volume":"114","author":"J Pidala","year":"2009","unstructured":"Pidala J, Anasetti C, Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood. 2009;114(1):7\u201319. https:\/\/doi.org\/10.1182\/blood-2008-10-182592.","journal-title":"Blood"},{"issue":"11","key":"2161_CR21","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/sj.bmt.1700806","volume":"19","author":"HJ Sutherland","year":"1997","unstructured":"Sutherland HJ, Fyles GM, Adams G, et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transpl. 1997;19(11):1129\u201336. https:\/\/doi.org\/10.1038\/sj.bmt.1700806.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"2161_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/01.NCC.0000265002.79687.AF","volume":"30","author":"DK Tierney","year":"2007","unstructured":"Tierney DK, Facione N, Padilla G, Dodd M. Response shift: a theoretical exploration of quality of life following hematopoietic cell transplantation. Cancer Nurs. 2007;30(2):125\u201338. https:\/\/doi.org\/10.1097\/01.NCC.0000265002.79687.AF.","journal-title":"Cancer Nurs"},{"issue":"3","key":"2161_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1200\/JCO.2005.03.189","volume":"23","author":"MA Andrykowski","year":"2005","unstructured":"Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23(3):599\u2013608. https:\/\/doi.org\/10.1200\/JCO.2005.03.189.","journal-title":"J Clin Oncol"},{"issue":"25","key":"2161_CR24","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1200\/JCO.2005.05.751","volume":"23","author":"JM Prieto","year":"2005","unstructured":"Prieto JM, Atala J, Blanch J, et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(25):6063\u201371. https:\/\/doi.org\/10.1200\/JCO.2005.05.751.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"2161_CR25","doi-asserted-by":"publisher","first-page":"E310","DOI":"10.3324\/haematol.2019.225326","volume":"105","author":"E Boberg","year":"2020","unstructured":"Boberg E, Kadri N, Winterling J, et al. Mental fatigue after allogeneic hematopoietic stem cell transplantation is associated with cognitive dysfunction, but not central nervous system inflammation. Haematologica. 2020;105(6):E310\u20134. https:\/\/doi.org\/10.3324\/haematol.2019.225326.","journal-title":"Haematologica"},{"key":"2161_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/bmt.2016.344","volume":"52","author":"P Esser","year":"2017","unstructured":"Esser P, Kuba K, Mehnert A, et al. Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT. Bone Marrow Transplant. 2017;52:753\u20138. https:\/\/doi.org\/10.1038\/bmt.2016.344.","journal-title":"Bone Marrow Transplant"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-022-02161-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T05:06:18Z","timestamp":1669698378000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-022-02161-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2161"],"URL":"https:\/\/doi.org\/10.1186\/s13014-022-02161-9","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local Ethics Board of the University of Regensburg approved this study (Ethics approval number 20-1810_1-101). The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"Daniel Wolff received honoraria from Neovii and Medac. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}